Asthma is increasingly recognised as a heterogeneous disease, with several phenotypes defined by clinical and inflammatory characteristics. Common phenotypes include allergic (eosinophilic, IgE-mediated), non-allergic (often neutrophilic or paucigranulocytic), late-onset adult asthma, obesity-associated asthma, and asthma with persistent airflow limitation.14 Identifying phenotypes supports individualised treatment strategies, particularly in those with severe asthma, and better long-term outcomes.
Steps 2 and 3: Maintenance and reliever therapy (MART)
Comorbid conditions can complicate asthma management. Assess for and help address factors such as allergic rhinitis, which affects up to 80% of people with asthma,24 as well as gastro-oesophageal reflux disease (GORD), anxiety, depression, obstructive sleep apnoea and smoking.
Going bush: rewards of rural pharmacy
Pharmacy in rural and remote areas has a lot to offer, from closer relationships with customers to higher pay, but these opportunities are often...
How to deal with stress in the pharmacy
Two experts set out how to deal with patient and pharmacist anxiety over myriad recent changes.
PSA to transform accreditation amid shake-up
With the AACP closing its doors at the end of the year, PSA is stepping up to become the new home of accreditation.
AstraZeneca COVID-19 vaccine and clotting: what to watch for
An expert panel has confirmed a second case of thrombosis with thrombocytopenia in Australia is likely linked to AstraZeneca’s COVID-19 vaccine.
Youngest 2023 influenza death recorded as vaccination lags
The recent death of a healthy 3-year-old boy from influenza is a reminder of the dangers of the virus and the importance of vaccination.
EC options underutilised by pharmacists
Community pharmacists could more frequently give patients a choice between the two emergency contraception drugs available in Australia.
The mystery shopper exercise conducted by University...
